Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 10, 2023 - Issue
Submit an article Journal homepage
161
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7

Jian-Qiang Jiang1 Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China;2 Department of Interventional Therapy, Nantong Tumor Hospital, Nantong, People’s Republic of China
,
Jin-Tao Huang1 Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China
,
Bin-Yan Zhong1 Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-9716-1211
ORCID Icon,
Wei-Dong Wang3 Department of Interventional Radiology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-7842-8969
ORCID Icon,
Jun-Hui Sun4 Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
,
Qi Wang5 Department of Interventional Radiology, Third Affiliated Hospital of Soochow University, Changzhou First Hospital, Changzhou, People’s Republic of China
,
Wen-Bin Ding6 Department of Interventional Radiology, Nantong First People’s Hospital, Nantong, People’s Republic of China
,
Cai-Fang Ni1 Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China
&
Xiao-Li Zhu1 Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 1629-1638 | Received 14 Jun 2023, Accepted 18 Sep 2023, Published online: 26 Sep 2023

Figures & data

Table 1 Patient Characteristics of CP-A/B (Score of 7–9) Patients with TACE Therapy Before Propensity Score Matching

Table 2 Patient Characteristics of CP-A/B (Score of 7–9) Patients with TACE Therapy After Propensity Score Matching

Table 3 Baseline Characteristics of CP-A/B (Score of 7) Patients with TACE Therapy Before and After Propensity Score Matching (PSM)

Figure 1 Flow chart of patient selection.

Abbreviations: HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; ECOG, Eastern Cooperative Oncology Group; BCLC, Barcelona Clinic Liver Cancer.
Figure 1 Flow chart of patient selection.

Figure 2 Kaplan–Meier survival curves stratified by the Child-Pugh class [Child-Pugh (A) vs Child-Pugh (B) (score of 7–9)] after propensity score matching.

Figure 2 Kaplan–Meier survival curves stratified by the Child-Pugh class [Child-Pugh (A) vs Child-Pugh (B) (score of 7–9)] after propensity score matching.

Figure 3 Kaplan–Meier survival curves stratified by the Child-Pugh class [Child-Pugh (A) vs Child-Pugh (B) (score of 8–9)] after propensity score matching.

Figure 3 Kaplan–Meier survival curves stratified by the Child-Pugh class [Child-Pugh (A) vs Child-Pugh (B) (score of 8–9)] after propensity score matching.

Figure 4 Kaplan–Meier survival curves stratified by the Child-Pugh class [Child-Pugh (A) vs Child-Pugh (B) (score of 7)] after propensity score matching.

Figure 4 Kaplan–Meier survival curves stratified by the Child-Pugh class [Child-Pugh (A) vs Child-Pugh (B) (score of 7)] after propensity score matching.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.